1. Introduction
===============

The insulin-like growth factors, IGF-I and IGF-II, are mitogenic polypeptides with important roles in cell growth and differentiation \[[@B1-cancers-02-00233]\]. The biological activities of IGF-I and IGF-II are mediated by the IGF-I receptor (IGF-IR) and are modulated by a family of IGF-binding proteins (IGFBPs) that control ligand bioavailability \[[@B2-cancers-02-00233],[@B3-cancers-02-00233],[@B4-cancers-02-00233]\]. The IGF-IR is essential for normal cell cycle progression and has a crucial role in tumor growth and metastasis development. Ligand-mediated activation of the IGF-IR tyrosine kinase domain leads to mitogenic and antiapoptotic effects in multiple cells and cancer-derived cell lines \[[@B5-cancers-02-00233]\]. In the specific context of breast tumorigenesis, the IGF-IR is overexpressed in most primary tumors \[[@B4-cancers-02-00233]\]. In addition, and consistent with its potent antiapoptotic role, IGF-IR-null cells do not undergo transformation when exposed to different oncogenes \[[@B6-cancers-02-00233],[@B7-cancers-02-00233]\]. On the other hand, inhibition of IGF-IR signaling by IGF-IR antibodies, antisense oligonucleotides, IGF-BPs, or specific IGF-IR kinase inhibitors results in reduced cell proliferation and cancer progression *in vivo* and *in vitro* \[[@B8-cancers-02-00233],[@B9-cancers-02-00233],[@B10-cancers-02-00233],[@B11-cancers-02-00233],[@B12-cancers-02-00233],[@B13-cancers-02-00233],[@B14-cancers-02-00233]\]. Furthermore, epidemiological studies revealed that high levels of circulating IGF-I are linked to an increased risk of developing breast cancer in premenopausal women \[[@B15-cancers-02-00233],[@B16-cancers-02-00233]\].

Regulation of IGF-IR gene expression is mainly attained at the transcription level. The IGF-IR promoter is a TATA-less, CCAAT-less, highly GC-rich, 'initiator'-type of promoter. IGF-IR gene transcription is dependent on a number of stimulatory zinc-finger nuclear proteins, including Sp1 \[[@B17-cancers-02-00233]\] and KLF6 \[[@B18-cancers-02-00233]\]. In addition, IGF-IR gene transcription is negatively regulated by several tumor suppressors, including BRCA1, p53/p63/p73, the von Hippel-Lindau protein (VHL), and the Wilms' protein-1 (WT1) \[[@B19-cancers-02-00233],[@B20-cancers-02-00233],[@B21-cancers-02-00233],[@B22-cancers-02-00233],[@B23-cancers-02-00233],[@B24-cancers-02-00233],[@B25-cancers-02-00233]\]. Interactions between stimulatory and inhibitory transcription factors play an important role in IGF-IR gene regulation and, therefore, were postulated to have a major impact on the proliferative status of the cell. The molecular mechanisms and specific transcription factors responsible for regulating IGF-IR gene expression in breast cancer cells, however, have not yet been identified.

The IGF-I and estrogen signaling systems were shown to act in a synergistic fashion in breast epithelial cells \[[@B25-cancers-02-00233]\]. Estrogens regulate IGF-I signaling and the expression of several members of the IGF system \[[@B25-cancers-02-00233],[@B26-cancers-02-00233],[@B27-cancers-02-00233],[@B28-cancers-02-00233],[@B29-cancers-02-00233],[@B30-cancers-02-00233],[@B31-cancers-02-00233]\]. Moreover, activation of estrogen receptor-α (ERα) by estrogens induces a physical interaction between ERα and IGF-IR \[[@B32-cancers-02-00233]\] that results in activation and phosphorylation of IGF-IR and downstream signaling molecules \[[@B33-cancers-02-00233],[@B34-cancers-02-00233],[@B35-cancers-02-00233],[@B36-cancers-02-00233]\]. The aim of this study was to identify the collections of IGF-IR promoter-binding transcription factors in ER-positive and ER-depleted breast cancer cells. Using DNA affinity chromatography, mass spectroscopy (MS), and Western blot analyses, we identified a series of known and previously unidentified transcription factors that specifically bind to the IGF-IR promoter in either cell type. The ability of selected proteins to bind and transactivate the IGF-IR promoter was confirmed by chromatin immunoprecipitation (ChIP) and transient transfection assays. In addition, we identified a number of non-DNA sequence-specific nuclear proteins that are probably involved in IGF-IR gene regulation. Identification of differentially expressed IGF-IR promoter-binding and non-binding transcription factors may help elucidate the mechanisms responsible for the differential expression of the IGF-IR gene in ER-positive and ER-depleted breast cancer cells.

2. Material and Methods
=======================

2.1. Cell Cultures
------------------

Human breast cancer-derived MCF7 cells \[(ER-positive), American Type Culture Collection, Manassas, VA, USA\] were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 50 μg/mL gentamicin sulfate, and 5.6 mg/L fungizone (Sigma-Aldrich Co., St. Louis, MO, USA). The C4.12.5 cell line was derived by clonal selection of MCF7 cells that were grown in the absence of estrogen for nine months \[[@B37-cancers-02-00233]\]. C4.12.5 cells were maintained in phenol red-free DMEM with 10% charcoal/dextran-treated FBS, 2 mM glutamine, and antibiotics. The C4.12.5 cell line was provided by Dr. Wade V. Welshons (University of Missouri, Columbia, MO, USA). Cells were incubated at 37 °C in a humidified atmosphere containing 5% CO~2~.

2.2. PCR and DNA Affinity Chromatography of the IGF-IR Promoter
---------------------------------------------------------------

For DNA affinity chromatography, a 511-bp human proximal IGF-IR promoter fragment extending from nucleotides −458 to +53 was labeled using a 5'-biotinylated antisense primer. This fragment includes most of the proximal 5\'-flanking region and comprises the '*initiator*' motif from which transcription starts *in vivo* (Nucleotide 1) ([Figure 1](#cancers-02-00233-f001){ref-type="fig"}).

Primer sequences were derived from genomic IGF-IR clone \#R73P2 \[[@B38-cancers-02-00233]\] as follows: sense, 5\'-CTTTCCAGCCGCGCTGTTGTTG-3\'; antisense, 5\'-(Biotin)-GGTAAACAAGAGCCCCAGCCTC-3\'. PCR was performed using the TermalAce^TM^ DNA Polymerase reagent (InVitrogen, Carlsbad, CA, USA). The biotinylated PCR product was bound to streptavidin magnetic beads (Dynabeads^®^ M-270 Streptavidin; Dynak Biotech ASA, Oslo, Norway), and incubated with nuclear extracts of MCF7 or C4.12.5 cells in the presence of double stranded poly dI-dC (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Following high-salt elution, specifically-bound proteins were resolved on 10% SDS-PAGE gels and visualized by silver staining ([Figure 2](#cancers-02-00233-f002){ref-type="fig"}). Gel slices were then submitted for MS analysis at the Smoler Proteomics Center (Technion-Israel Institute of Technology, Haifa, Israel) or analyzed by Western blotting as described below.

![IGF-IR promoter. (A) Schematic representation of the IGF-IR promoter region \[[@B5-cancers-02-00233]\]. The initiator (INR) element is denoted by an arrow. The coding region, starting with the AUG codon, is shown in gray. The translation start site is denoted by a dashed arrow. The 5'-flanking region is denoted by a black bar, and the 5'-untranslated region (UTR) is represented by a dotted bar. The location of primers (P\#1 and P\#2), employed to amplify the proximal promoter is indicated. (B) PCR amplification of the human IGF-IR promoter. The PCR reaction was performed using a biotinylated antisense primer, as described under *Materials and Methods* section, and 4 μL of the biotinylated PCR product was loaded on a 1% agarose gel. A PCR reaction without DNA served as negative control. A 100-bp DNA ladder was used as a M.W. marker.](cancers-02-00233-g001){#cancers-02-00233-f001}

![Silver staining of IGF-IR promoter-bound proteins identified by DNA affinity chromatography. Nuclear extracts of MCF7 cells were prepared as described under *Materials and Methods* Section. Proteins bound to IGF-IR promoter DNA (10 μg) were electrophoresed through 10% SDS-PAGE, fixed, and stained with silver (Bio-Rad, Hercules, CA, USA). Lane 1, M.W. marker; lane 2, starting material (MCF7 nuclear extract, 4.2 μg); lane 3, unbound material (MCF7 nuclear extract that did not bind to DNA, 4.2 μg); lane 4, eluted material bound to Biotin-520 bp (MCF7 nuclear proteins that bound to IGF-IR promoter, 10 μg); and lane 5, negative control (MCF7 nuclear proteins bound to strepavidin magnetic beads, 10 μg).](cancers-02-00233-g002){#cancers-02-00233-f002}

2.3. Gel Slices Proteolysis and Mass Spectroscopy Analysis
----------------------------------------------------------

The gel slices containing the specific DNA-bound proteins were reduced with 10 mM DTT, incubated at 60 °C for 30 min, carboxyamidomethylated with 40 mM iodoacetamide at room temperature for 30 min, and trypsinized overnight at 37 °C \[modified trypsin (Promega)\] at a 1:100 enzyme-to-substrate ratio. The tryptic peptides were resolved by reverse-phase chromatography on 0.075 × 200-mm fused silica capillaries (J&W, Wilmington, DE, USA) packed with Reprosil reversed phase material (Dr Maisch GmbH, Germany). The peptides were eluted with a linear 90 min gradient from 5 to 45% acetonitrile containing 0.1% formic acid, followed by a wash of 95% acetonitrile for 15 min. The flow rate was 0.25 μl/min and the peptides were electrosprayed into an ion-trap mass spectrometer (Orbitrap, Thermo Fisher Scientific Inc., USA). MS was performed in a positive mode using repetitively full MS scans followed by collision induced dissociation (CID) of the 7 most dominant ions selected from the first MS scan. The MS data was clustered and analyzed using the Sequest software (Finnigan, San Jose, CA, USA) and Pep-Miner \[[@B39-cancers-02-00233]\] searching against International Protein Index (IPI) protein IDs (part of the NR-NCBI database).

2.4. Cell Fractionation
-----------------------

Whole cell extracts were prepared by lysing cells in a buffer containing protease inhibitors, as described previously \[[@B20-cancers-02-00233]\]. To prepare cytosolic and nuclear extracts, cells were washed with ice-cold phosphate-buffered saline (PBS), centrifuged, and the pellet was resuspended in buffer A \[10 mM Hepes (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 2 μg/mL aprotinin, 1 mM ortovanadate, 2 μg/mL leupeptin, 4 mM pyrophosphate, 2 μg/mL pepstatin, and 1 mM PMSF\] and incubated for 30 min on ice. IGEPAL (CA-630, Sigma-Aldrich Co.) was then added to a final concentration of 3%, vortexed, and centrifuged (14,000 rpm, 30 sec), after which the supernatant containing the cytosolic fraction was saved at −70 °C. Buffer C \[20 mM Hepes, 420 mM NaCl, 1 mM EDTA, 1 mM EGTA, and protease inhibitors\] was added to the nuclei-containing pellet, incubated for 30 min at room temperature, and spun at 14,000 rpm for 5 min. The supernatant containing the nuclear extract was frozen at −70 °C. Protein concentrations were determined with the Bradford reagent (Bio-Rad, Hercules, CA, USA) using bovine serum albumin (BSA) as a standard.

2.5. Western Immunoblots
------------------------

Samples were electrophoresed through 12%, 10%, or 7.5% SDS-PAGE gels, followed by blotting of the proteins onto nitrocellulose membranes. After blocking with either skim milk or 3% BSA, the blots were incubated overnight with the antibodies listed below, washed and incubated with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody. Antibodies against BRCA1 (C-20), TOPOII (C-15), MET (C-28), p120 (H-90), androgen receptor \[(AR), N-20\], IGF-IR β-subunit (C-20), Sp1 (PEP2), TCF3A (M-20), c-fos (4), ER α (MC-20), WT1 (C-19), KLF6 (R-173), lamin A/C (636), Smad2/3 (FL-425), c-Myc (9E10), p63 (4A4), E2F1 (KH95), LEF1 (C-19), TCF1A (C-21), p53 (mixture of DO-1 and Pab 1801), GSK3β (11B7), phospho c-jun (KM-1), cyclin D (H295), cyclin G (F-5), histone1 (FL-219), β-catenin (E-5), p300 (C-20), BRCA2 (H-300), TLE-1 (M-101), p21 (C-19), normal mouse IgG \[NMS (SC-2025)\], and normal rabbit IgG \[NRS (SC-2027)\] were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). An antibody against tubulin (Clone: B-5-1-2) was purchased from Sigma-Aldrich Co. Anti IRS-1 was kindly provided by Dr. Hagit Eldar-Finkelman (Tel Aviv University). Antibodies against poly ADP ribose polymerase \[(PARP); 9542 and 9532\], phospho-IGF-IR (3024), Foxo1 (9462), and phospho-Smad2 (3101) were obtained from Cell Signaling Technology (Beverly, MA, USA). In addition, the following antibodies were used: p73 (Ab-1; Oncogene Research Products, San Diego, CA, USA), c-jun (610326; BD Transduction Laboratories, Franklin Lakes, NJ, USA), APC (OP47L; Calbiochem, San Diego, CA, USA) and hemagglutinin (HA-11; Berkeley Antibody Company, Richmond, CA, USA). The secondary antibodies were HRP-conjugated bovine (1:500) or donkey (1:500) anti-goat IgG (both from Santa Cruz Biotechnology), goat anti-rabbit IgG (1:50,000) and donkey anti-mouse IgG (1:25,000; Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Proteins were detected using the SuperSignal West PicoChemiluminescent Substrate (Pierce, Rockford, IL, USA).

2.6. Chromatin Immunoprecipitation Assays
-----------------------------------------

The ChIP assays were performed as described previously \[[@B40-cancers-02-00233]\]. Briefly, MCF7 cells were cross-linked with 1% formaldehyde at 37 °C for 10 min. Cells were rinsed with ice-cold PBS and centrifuged. The pellet was then resuspended in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1 and protease inhibitor mixture: 1 mM PMSF, 1 μg/mL aprotinin and 1 μg/ml pepstatin A) and sonicated for 3 min. The supernatant fraction was immunoprecipitated with anti-PARP, anti-c-jun, anti-Sp1, anti-KLF6, anti-HA, and NRS or NMS for 18 h at 4°C. The next day, Protein A/G plus agarose beads (SC-20003, Santa Cruz Biotechnology) was added for one hour at 4 °C. Immunoprecipitates were electrophoresed and immunoblotted as described under *Western immunoblots*. For PCR analysis of antibody-immunoprecipitated chromatin, a set of primers encompassing the IGF-IR proximal promoter region, sense, 3\'-CCAGCCGCGCTGTTGTTG-5\', anti-sense: 3-CCAGCCGCGCTGTTGTTG-5, and Thermolace^TM^ DNA polymerase kit were used.

2.7. DNA Transfections
----------------------

For transient cotransfection experiments an IGF-IR promoter luciferase reporter construct including 476 bp of 5\'-flanking and 640 bp of 5\'-untranslated regions of the IGF-IR gene \[p(−476/+640) luciferase (LUC)\] was employed \[[@B41-cancers-02-00233],[@B42-cancers-02-00233]\]. An expression vector encoding c-jun (RSV-c-jun) was provided by Dr. Lili Vardimon (Tel Aviv University). An HA-HMGA1 expression vector (in pcDNA3) was provided by Dr. G. Manfioletti (University of Trieste, Italy) \[[@B43-cancers-02-00233]\]. A KLF6 expression vector (pCI-neo-KLF6) was provided by Dr. Scott L. Friedman (Mount Sinai School of Medicine, New York, USA). The E2F1 expression vector, pcDNA-I-E2F-1, was previously described \[[@B44-cancers-02-00233]\]. Cells were seeded in six-well plates the day before transfection and cotransfected with 1 μg of the IGF-IR promoter reporter along with 1μg of the E2F1 expression plasmid (or empty pCDNA3), or 2 μg of the HA-HMGA1 (or empty pCDNA3), or 2 μg of the pCI-neo-KLF6 (or empty pCI-neo) using the Jet-PEI (Polyplus, Illkirch, France) transfection reagent. Cells were harvested 48 h after transfection, and luciferase activity was measured as previously described \[[@B41-cancers-02-00233]\]. Promoter activities were expressed as luciferase values normalized to protein concentrations. Protein content was determined using the Bradford reagent (Bio-Rad, Hercules, CA, USA) using BSA as a standard.

3. Results
==========

3.1. ER and IGF-IR Expression in MCF7 and C4.12.5 Cells
-------------------------------------------------------

The involvement of the IGF-IR in breast cancer development has been well established. To address the potential regulation of IGF-IR expression during breast cancer progression, we measured in initial experiments the levels of total and phospho-IGF-IR (pIGF-IR) in syngeneic cell lines representing different stages of the disease. For this purpose, we employed the human breast cancer-derived MCF7 (ER-positive) and MCF7-derived C4.12.5 (ER-depleted) cell lines. C4.12.5 cells were generated by clonal selection of MCF7 cells that were maintained in estrogen-free conditions for nine months \[[@B37-cancers-02-00233]\]. Although C4.12.5 cells exhibited some variability in ER expression, the passages used in the present study displayed consistently low levels of ERα (\~59% of the ERα levels in MCF7 cells). Western blots using anti-IGF-IR β-subunit and anti-pIGF-IR antibodies showed that both total IGF-IR and pIGF-IR levels were significantly reduced in C4.12.5, in comparison to, MCF7 cells (76% for IGF-IR and 30% for pIGF-IR) ([Figure 3](#cancers-02-00233-f003){ref-type="fig"}). These results corroborate previous observations \[[@B40-cancers-02-00233],[@B45-cancers-02-00233]\].

![IGF-IR and ERα expression in MCF7 and C4.12.5 breast cancer cell lines.MCF7 and C4.12.5 cells were lysed as described under *Materials and Methods*. Cellular extracts (80 μg) were electrophoresed through 10% SDS-PAGE, transferred to nitrocellulose membranes, and blotted with anti-total IGF-IR-β, anti-pIGF-IR, and anti-ERα. Blots were then blotted with a tubulin antibody as a loading control.](cancers-02-00233-g003){#cancers-02-00233-f003}

3.2. DNA Affinity Chromatography
--------------------------------

The MCF7 and C4.12.5 cell lines were employed to identify the sets of IGF-IR promoter-binding proteins that may be involved in IGF-IR transcription and that are responsible for the differential expression of the gene at different stages of the disease. The rationale for these studies was the fact that regulation at the transcription level has been identified as a major control step in IGF-IR regulation \[[@B46-cancers-02-00233]\]. To this end, we used a proteomic approach based on DNA affinity chromatography followed either by MS or Western blot analyses using antibodies against previously identified or novel IGF-IR promoter-binding proteins. The basis for selecting this specific fragment was the fact that previous studies have shown that this region is responsible for most of the promoter activity. Nuclear extracts of MCF7 and C4.12.5 cells were incubated with the PCR-amplified, biotin-labeled IGF-IR proximal promoter DNA probe, after which DNA-protein complexes were adsorbed to streptavidin beads. Bound proteins were eluted with high-salt buffer and concentrated by centrifugation at reduced pressure. The eluted material was electrophoresed through 10% SDS-PAGE and proteins were visualized by silver staining ([Figure 2](#cancers-02-00233-f002){ref-type="fig"}). A number of bands were seen in the eluted material (lane 4) whereas no proteins were detected in eluates of lysates incubated with strepavidin magnetic beads alone (lane 5). Silver stained gels were cut into slices and the specific DNA-bound proteins were analyzed by MS.

3.3. MS Analysis
----------------

MS analysis of DNA affinity chromatography-purified proteins identified a number of previously reported and several novel IGF-IR promoter binding proteins. The proteins identified were categorized using the Gi (gene index) identification tool, coverage (percentage of amino acids covered by the identified peptide), and source ([Table 1](#cancers-02-00233-t001){ref-type="table"}). The specific proteins bound to the IGF-IR promoter were classified based on cellular localization and biological function ([Table 2](#cancers-02-00233-t002){ref-type="table"}). Most of the proteins were localized in the nucleus, but some of them were found also in the cytoplasm as well as in the plasma membrane. Furthermore, [Table 2](#cancers-02-00233-t002){ref-type="table"} illustrates the variety of biological processes associated with the identified IGF-IR promoter-binding transcription factors in ER-positive and ER-depleted breast cancer cells. Out of 91 proteins identified by MS, 6 correspond to cytoskeleton-associated proteins, 6 are involved in transcription, regulation of nucleobase, nucleoside and nucleic acid metabolism, 2 in nuclear stability, chromatin structure, cycle control, and gene expression, 20 in DNA repair, breaking, replication, and cell death, 24 in RNA splicing and processing, and translation, and 33 in other functions, including proliferation, apoptosis, and proteosomal degradation.

cancers-02-00233-t001_Table 1

###### 

IGF-IR promoter-binding proteins identified by MS in MCF7 and C4.12.5 cells.

              Protein Name                                                                          Coverage   Coverage      Source
  ----------- ------------------------------------------------------------------------------------- ---------- ------------- -------------------------
                                                                                                    **MCF7**   **C4.12.5**   
  4760598     Adenylate kinase isozyme 2                                                            4          \-            Mus musculus
  61743954    AHNAK nucleoprotein isoform 1                                                         1          3             Homo sapiens
  1061128     Anpg                                                                                  25         21            Homo sapiens
  5453541     Anterior gradient 2 homolog                                                           26         −             Homo sapiens
  6753086     Apurinic/apyrimidinic endonuclease 1                                                  8          −             Mus musculus
  10947139    Arginase, type I                                                                      −          3             Homo sapiens
  6680748     ATP synthase, H^+^ transporting, mitochondrial F1 complex, alpha subunit, isoform 1   3          7             Mus musculus
  10863945    ATP-dependent DNA helicase II                                                         20         28            Homo sapiens
  4503841     ATP-dependent DNA helicase II, 70 kDa subunit                                         22         28            Homo sapiens
  1040689     ATP-dependent DNA helicase Q1 (DNA-dependent ATPase Q1)                               \_         4             Homo sapiens
  42740907    Clusterin isoform 2                                                                   −          8             Homo sapiens
  22208854    Cytidine monophospho-N-acetylneuraminic acid synthetase                               3          3             Mus musculus
  4557515     Damage-specific DNA binding protein 2 (48kD)                                          6          18            Homo sapiens
  45476309    Damage-specific DNA binding protein 2 splicing variant D4                             7          13            Homo sapiens
  4758138     DEAD (Asp-Glu-Ala-Asp) box polypeptide 5                                              15         13            Homo sapiens
  506756      Desmoyokin                                                                            −          6             
  1706481     DNA ligase III                                                                        23         37            Homo sapiens
  11225260    DNA topoisomerase I                                                                   10         11            Homo sapiens
  347019      DnaK-type molecular chaperone hsp72-ps1                                               8          10            Rattus norvegicus
  1722884     DNA-repair protein complementing XP-C cells                                           −          6             Drosophila melanogaster
  38201714    ELAV-like 1                                                                           10         −             Homo sapiens
  4503471     Eukaryotic translation elongation factor 1 α 1                                        6          2             Homo sapiens
  4503477     Eukaryotic translation elongation factor 1 β 2                                        7          −             Homo sapiens
  25453472    Eukaryotic translation elongation factor 1 δ isoform 2                                22         −             Homo sapiens
  110625979   Eukaryotic translation elongation factor 1 γ                                          6          −             Mus musculus
  37078458    Far upstream element-binding protein 1 (FUSE-binding protein 1)                       11         13            Mus musculus
  27806887    Fusion (involved in t(12;16) in malignant liposarcoma)                                5          \_            Bos taurus
  7669492     Glyceraldehyde-3-phosphate dehydrogenase                                              9          −             Mus musculus
  74736618    Grainyhead-like protein 2 homolog                                                     −          16            Homo sapiens
  51316135    GTP-binding nuclear protein Ran, testis-specific isoform                              10         −             Rattus norvegicus
  4504517     Heat shock 27kDa protein 1                                                            33         −             Homo sapiens
  2495339     Heat shock 70 kDa protein 1B                                                          8          10            Bos taurus
  8393547     Heterogeneous nuclear ribonucleoprotein A1                                            13         11            Rattus norvegicus
  14043072    Heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1                              19         10            Homo sapiens
  31559916    Heterogeneous nuclear ribonucleoprotein A3 isoform a                                  11         15            Mus musculus
  55956919    Heterogeneous nuclear ribonucleoprotein AB isoform a                                  9          3             Homo sapiens
  14249959    Heterogeneous nuclear ribonucleoprotein C (C1/C2)                                     10         2             Homo sapiens
  870747      Heterogeneous nuclear ribonucleoprotein D (hnRNP D)                                   11         22            Homo sapiens
  10946928    Heterogeneous nuclear ribonucleoprotein H1                                            13         8             Mus musculus
  14141157    Heterogeneous nuclear ribonucleoprotein H3 isoform a                                  11         −             Homo sapiens
  13384620    Heterogeneous nuclear ribonucleoprotein K                                             23         10            Mus musculus
  133274      Heterogeneous nuclear ribonucleoprotein L (hnRNP L)                                   4          4             Homo sapiens
  14141152    Heterogeneous nuclear ribonucleoprotein M isoform a                                   15         18            Homo sapiens
  5031755     Heterogeneous nuclear ribonucleoprotein R isoform 2                                   6          6             Homo sapiens
  8393536     High mobility group box 2                                                             14         −             Rattus norvegicus
  1568557     Histone H2B                                                                           19         12            Homo sapiens
  968888      HMG-1                                                                                 13         −             Homo sapiens
  32358       HnRNP U protein                                                                       11         9             Homo sapiens
  37183160    HRPE773                                                                               −          29            Homo sapiens
  1040689     Human Diff6, H5, CDC10 homologue, KIAA0097                                            6          −             Homo sapiens
  13385872    Interleukin enhancer binding factor 2                                                 8          13            Mus musculus
  4504865     KH-type splicing regulatory protein (FUSE binding protein 2)                          6          8             Homo sapiens
  6453818     Kinesin family member 22                                                              −          20            Homo sapiens
  2055427     KSRP                                                                                  5          26            Homo sapiens
  27436946    Lamin A/C isoform 1 precursor                                                         20         15            Homo sapiens
  5031877     Lamin B1                                                                              8          21            Homo sapiens
  14149645    Methyl CpG binding protein 2                                                          4          4             Mus musculus
  1770458     M-phase phosphoprotein 4                                                              12         6             Homo sapiens
  4038587     Mucin                                                                                 −          2             Homo sapiens
  55956788    Nucleolin                                                                             5          5             Homo sapiens
  58037163    Nucleoporin 35                                                                        6          −             Mus musculus
  35119       NuMA protein                                                                          −          2             Homo sapiens
  1483131     p80 protein                                                                           3          3             Homo sapiens
  115497186   Paraspeckle component 1                                                               2          7             Bos taurus
  156523968   Poly (ADP-ribose)polymerase                                                           32         36            Homo sapiens
  14141166    Poly(rC)-binding protein 2 isoform b                                                  20         9             Homo sapiens
  31543419    Polynucleotide kinase 3 phosphatase                                                   13         11            Homo sapiens
  4506243     Polypyrimidine tract-binding protein 1 isoform a                                      8          10            Homo sapiens
  4502801     Regulator of chromosome condensation (RCC1)                                           12         10            Homo sapiens
  4506583     Replication protein A1, 70kDa                                                         18         26            Homo sapiens
  4506585     Replication protein A2, 32kDa                                                         7          −             Homo sapiens
  4506439     Retinoblastoma binding protein 7                                                      3          −             Homo sapiens
  15718687    Ribosomal protein S3                                                                  23         −             Homo sapiens
  7159943     RNA and export factor binding protein 1-II                                            24         9             Mus musculus
  4757926     RNA binding motif protein 39 isoform b                                                3          −             Homo sapiens
  66346679    SERPINE1 mRNA binding protein 1 isoform 1                                             9          9             Homo sapiens
  2440078     SPIN protein                                                                          −          4             Homo sapiens
  4826998     Splicing factor proline/glutamine rich                                                9          11            Homo sapiens
  5902076     Splicing factor, arginine/serine-rich 1 isoform 1                                     4          −             Homo sapiens
  39930517    Sterile alpha motif domain containing 1                                               11         17            Homo sapiens
  30088600    Telomerase subunit EST1A                                                              1          1             Homo sapiens
  4507555     Thymopoietin isoform alpha                                                            8          17            Homo sapiens
  4507401     Transcription factor A, mitochondrial                                                 4          \-            Homo sapiens
  14389309    Tubulin alpha 6                                                                       6          12            Homo sapiens
  12963615    Tubulin, beta 3                                                                       9          8             Mus musculus
  21361322    Tubulin, beta 4                                                                       9          9             Homo sapiens
  1066004     Typr II DNA topoisomerase beta isoform                                                −          1             Mus musculus
  28077011    Tyrosyl-DNA phodphodiesterase 1                                                       4          4             Mus musculus
  4506387     UV excision repair protein RAD23 homolog B                                            4          −             Homo sapiens
  2632123     Xeroderma Pigmentosum Group E Complementing protein                                   7          17            Homo sapiens
  5454172     X-ray repair cross complementing protein 1                                            9          12            Homo sapiens

Gi: identification tool; Coverage: percentage of amino acids covered by the identified peptide (n = 3 independent analyses).

cancers-02-00233-t002_Table 2

###### 

Summary of functional categories of IGF-IR promoter-bound proteins identified by MS.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                                                                                                                                                                            Subcellular fraction   Function
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Cytoskeleton-associated proteins*                                                                                                                                                                     

  KIAA0097 ; Human Diff6                                                                                                                                                          Cytoplasm\             Microtubule associated protein.
                                                                                                                                                                                  Nucleus                

  Kinesin family member 22                                                                                                                                                        Nucleus                Microtubule-dependent molecular motor.

  NuMA protein                                                                                                                                                                    Nucleus                Component of the mitotic spindle matrix.

  -Tubulin α 6-Tubulin, β 3-Tubulin, β 4                                                                                                                                          Cytoplasm\             Related to microtubules.
                                                                                                                                                                                  Nucleus                

  *Factors involved in transcription, regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism*                                                                                      

  -Elongation factor-1 (EF1)-Eukaryotic translation elongation factor 1 β 2-Eukaryotic translation elongation factor 1 δ isoform 2-Eukaryotic translation elongation factor 1 γ   Cytoplasm\             Involved in enzymatic delivery of aminoacyl tRNAs to the ribosome.
                                                                                                                                                                                  Nucleus                

  Poly(rC)-binding protein 2 isoform b                                                                                                                                            Cytoplasm\             RNA binding protein involved in regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism.
                                                                                                                                                                                  Nucleus                

  Telomerase subunit EST1A\                                                                                                                                                       Nucleus\               Telomere regulation.
  Alternative name: Chromosome 17 open reading frame 31\                                                                                                                          Nucleolus              
  Est1p like protein A\                                                                                                                                                                                  
  Ever shorter telomeres 1                                                                                                                                                                               

  *Nuclear stability, chromatin structure, cycle control, gene expression*                                                                                                                               

  -Lamin B1-Lamin A/C                                                                                                                                                             Nucleus                Nuclear stability, chromatin structure and gene expression.

  *Proteins with a known function in DNA repair, breaking, replication, transcription and cell death*                                                                                                    

  Apurinic/apyrimidinic endonuclease 1                                                                                                                                            Nucleus                DNA repair and redox regulatory activities.

  ATP-dependent DNA helicase II, 70 kDa subunit\                                                                                                                                  Nucleus                Repair of nonhomologous DNA ends.
  ATP-dependent (80 kda)                                                                                                                                                                                 

  ATP-dependent DNA helicase Q1 (DNA-dependent ATPase                                                                                                                             Nucleus                Repair of UV-irradiated DNA damage or other mutagens.

  -Damage-specific DNA binding protein (127kDa) --DDB1-Damage-specific DNA binding protein 2 (48kD) -- DDB2-Damage-specific DNA binding protein 2 splicing variant D4             Cytoplasm\             Repair of UV-irradiated DNA damage.
                                                                                                                                                                                  Nucleus                

  -DNA Topoisomerase I-DNA Topoisomerase II-Tyrosyl-DNA phosphodiesterase 1                                                                                                       Cytoplasm\             Type I topoisomerase breaks single DNA strands, whereas Type II topoisimerase breaks double stranded DNA.
                                                                                                                                                                                  Nucleus\               
                                                                                                                                                                                  Nucleoplasm            

  -High mobility group box 2-High Mobility Group Protein 17 (HMG17) --chromosomal protein-HMG1                                                                                    Nucleus                DNA repair, recombination, replication, and transcription.

  Histone 1,2 and 3                                                                                                                                                               Nucleus                Play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability.

  Poly (ADP-ribosylation) polymerase I-PARP-1                                                                                                                                     Nucleus                DNA repair, replication, transcription and cell death.

  Polynucleotide kinase 3 phosphatase                                                                                                                                             Nucleus                DNA repair following ionizing radiation or oxidative damage.

  Replication protein A1, 70kDa\                                                                                                                                                  Nucleus                Replication, recombination and DNA repair.
  Replication Protein A2, 32-KD; RPA2                                                                                                                                                                    

  Ribosomal Protein S3; RPS3                                                                                                                                                      Cytoplasm\             DNA repair and apoptosis.
                                                                                                                                                                                  Nucleus                

  Xeroderma Pigmentosum Group E\                                                                                                                                                  Cytoplasm\             Involved in DNA repair.
  Complementing protein                                                                                                                                                           Nucleus                

  X-ray repair cross complementing protein 1                                                                                                                                      Nucleus                Repair of single-strand DNA breaks.

  *RNA slipicing, RNA processing, Transcription, Translation and other functions*                                                                                                                        

  -Dead/H-box-5-RNA Helicase p68                                                                                                                                                  Nucleus                Implicated in cellular processes involving alteration of RNA secondary structure.

  ELAV-like 1                                                                                                                                                                     Cytoplasm\             RNA-binding proteins.
                                                                                                                                                                                  Nucleus                

  Fusion (involved in t(12;16) in malignant liposarcoma)                                                                                                                          Nucleus                Plays a role in maintenance of genomic integrity.

  hnRNP U protein                                                                                                                                                                 Cell surface Nucleus   Binds to pre-mRNA.

  Interleukin enhancer binding factor 2 variant                                                                                                                                   Nucleus\               Regulates transcription of the IL2 gene during T-cell activation.
                                                                                                                                                                                  Nucleolus              

  Nucleolin                                                                                                                                                                       Nucleus\               The major nucleolar protein of growing eukaryotic cells.
                                                                                                                                                                                  Nucleolus              

  RNA and export factor binding protein 1                                                                                                                                         Cytoplasm\             Nuclear mRNA export pathway.
                                                                                                                                                                                  Nucleus                

  RNA binding motif protein 39 isoform b                                                                                                                                          Nucleus                Transcriptional coactivator for steroid nuclear receptors ESR1/ER α and ESR2/ER-β, and JUN/AP-1.

  -Splicing factor, arginine/serine-rich 1 isoform 1-Splicing factor proline/glutamine rich                                                                                       Cytoplasm\             Prevents exon skipping.
                                                                                                                                                                                  Nucleus                

  *Others*                                                                                                                                                                                               

  Adenylate kinase isozyme 2                                                                                                                                                      Membrane\              Small ubiquitous enzyme.
                                                                                                                                                                                  Microsomal\            
                                                                                                                                                                                  Mitochondria\          
                                                                                                                                                                                  Nucleus                

  Alkyladenine DNA glycosylase (AAG), also known as 3-methyladenine DNA glycosylase,                                                                                              Nucleus                Catalyzes the first step in base excision repair.

  Arginase, type I                                                                                                                                                                Mitochondria           Plays a role in the regulation of extra-urea cycle arginine metabolism.

  ATP synthase, H+ transporting, mitochondrial F1 complex, α subunit, isoform 1                                                                                                   Mitochondria\          Produces ATP from ADP in the presence of a proton gradient across the membrane.
                                                                                                                                                                                  Cytoplasm\             
                                                                                                                                                                                  Nucleus                

  BBF2H7/FUS protein                                                                                                                                                              Nucleus                Binds both single-stranded and double-stranded DNA and promotes ATP-independent annealing of complementary single-stranded DNAs and d-loop formation in superhelical double-stranded.

  Clusterin                                                                                                                                                                       Cytoplasm\             Undefined function, being described as being both pro-apoptotic and anti- apoptotic.
                                                                                                                                                                                  Nucleus                

  Cytidine monophospho-N-acetylneuraminic acid synthetase                                                                                                                         Cytoplasm\             Involved in the biosynthesis of sialo-glycoproteins and gangliosides.
                                                                                                                                                                                  Nucleus                

  Desmoyokin/AHNAK                                                                                                                                                                Plasma Membrane\       Involved in the formation of cytoskeletal structure, calcium homeostasis, and muscle regeneration.
                                                                                                                                                                                  Cytoplasm\             
                                                                                                                                                                                  Nucleus                

  DNA ligase III α and β                                                                                                                                                          Nucleus                Interacts with DNA-repair protein XRCC1 and corrects defective DNA strand-break repair and sister chromatid exchange.

  -DnaK-type molecular chaperone hsp72-ps1-Heat shock 27 kD protein 1-Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8).                                            Cytosol\               Chaperone activity, thermotolerance, inhibition of apoptosis, regulation of cell development and cell differentiation.
                                                                                                                                                                                  Perinuclear\           
                                                                                                                                                                                  Mitochondria\          
                                                                                                                                                                                  Endoplasmatic\         
                                                                                                                                                                                  Reticulum\             
                                                                                                                                                                                  Nucleus                

  DNA-repair protein complementing                                                                                                                                                Nucleus                Nucleotide excision repair (NER) of DNA.

  -Far upstream element-binding protein 1 (FUSE-binding protein 1)-KH-type splicing regulatory protein (FUSE binding protein 2)-KSRP                                              Nucleus (Probable).    Regulates MYC expression by binding to a far-upstream element (FUSE) upstream of the MYC promoter.

  Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3)                                                                           Nucleus                Transcription factor involved in epidermal differentiation.

  GTP-binding nuclear protein Ran, testis-specific isoform                                                                                                                        Cytoplasm\             Nuclear transport pathways, required for the import of protein into the nucleus and also for RNA export.
                                                                                                                                                                                  Nucleus                

  Gyceraldehyde-3-phosphate dehydrogenase                                                                                                                                         Membrane\              Carbohydrate metabolism and membrane trafficking in the early secretory pathway.
                                                                                                                                                                                  Cytoplasm\             
                                                                                                                                                                                  Nucleus                

  Methyl CpG binding protein 2                                                                                                                                                    Nucleus                Nuclear proteins containing a methyl-binding domain (MBD)

  M-phase phosphoprotein 4                                                                                                                                                        Nucleolus              Regulation of cell cycle, cell communication and signal transduction.

  Mucin                                                                                                                                                                           Cytoplasm\             Activation of Wnt target genes.
                                                                                                                                                                                  Mitochondria\          
                                                                                                                                                                                  Nucleus                

  Nucleoporin 35 \[Nuclear pore glycoprotein-210 (gp210)\]                                                                                                                        Membrane\              Trafficking regulator in the eukaryotic nuclear pore complex.
                                                                                                                                                                                  Cytoplasm\             
                                                                                                                                                                                  Nucleus                

  p80 protein                                                                                                                                                                     Cytoplasm\             Part of the nuclear coiled bodies (CBS) involved in assembly/disassembly of nucleoplasmic snRNPs.
                                                                                                                                                                                  Nucleus                

  Paraspeckle component 1                                                                                                                                                         Cytoplasm\             Regulates cooperatively with NONO and SFPQ, androgen receptor-mediated gene transcription activity.
                                                                                                                                                                                  Nucleus\               
                                                                                                                                                                                  Nucleolus              

  PREDICTED: similar to RAN protein                                                                                                                                               Cytoplasm\             Inhibits GTP exchange on Ran.
                                                                                                                                                                                  Nucleus                

  Regulator of chromosome condensation (RCC1)                                                                                                                                     Cytoplasm\             Promotes the exchange of Ran-bound GDP by GTP.
                                                                                                                                                                                  Nucleus                

  Retinoblastoma binding protein 7                                                                                                                                                Nucleus                Modulates the functions ascribed to BRCA1 in transcriptional regulation, DNA repair, and/or cell cycle checkpoint control.

  SERPINE1 mRNA binding protein 1 isoform 1                                                                                                                                       Cytoplasm\             Regulates mRNA stability.
                                                                                                                                                                                  Nucleus                

  SPIN                                                                                                                                                                            Nucleus                Regulation of cell cycle

  Sterile alpha motif domain containing 1                                                                                                                                         Nucleus                Widespread domain in signalling and nuclear proteins.

  Thymopoietin γ and β ( TMPOs)                                                                                                                                                   Nucleus                Directs the assembly of the nuclear lamina.

  Transcription factor A, mitochondrial                                                                                                                                           Mitochondria           Involved in mitochondrial transcription regulation.

  UV excision repair protein RAD23 homolog B                                                                                                                                      Cytoplasm\             Plays a role both in proteosomal degradation of misfolded proteins and DNA repair.
                                                                                                                                                                                  Nucleus                
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

3.4. Identification of IGF-IR Promoter-Binding Transcription Factors by Western Blots
-------------------------------------------------------------------------------------

Western blot analysis of DNA affinity chromatography-purified proteins identified a number of previously reported as well as novel IGF-IR promoter binding proteins. The data are summarized in [Figure 4](#cancers-02-00233-f004){ref-type="fig"} and [Table 3](#cancers-02-00233-t003){ref-type="table"} and [Table 4](#cancers-02-00233-t004){ref-type="table"}. Consistent with their role as positive regulators of the IGF-IR gene, the binding of zinc finger proteins Sp1 and KLF6 to the IGF-IR promoter was stronger in MCF7 than in C4.12.5 cells. Similarly, ER-α binding to the IGF-IR promoter was stronger in MCF7 than in C4.12.5 cells. On the other hand, a number of transcription factors, including AR, Smad2/3, E2F1, c-jun, TCF1A, TCF3A, GSK3β, and p21 appear to bind to the promoter region only in the C4.12.5 cell line. p53, c-fos, and PARP bind to IGF-IR promoter elements in both cell lines with similar affinity. No DNA binding was detected in either cell line using antibodies against BRCA1, TOPOII, IRS-1, MET, p120, Foxo1, p73, lamin A/C, c-Myc, p63, cyclin D, cyclin G, histone1, and BRCA2.

![IGF-IR promoter-binding transcription factors identified by Western blots in the MCF7 and C4.12.5 cell lines. DNA chromatography eluates were electrophoresed though 10% SDS-PAGE and blotted with the antibodies listed under *Materials and Methods* Section. The left lanes correspond to nuclear extracts (NE; 4.2 μg) and the right lanes correspond to DNA affinity chromatography eluates (E; 10 μg).](cancers-02-00233-g004){#cancers-02-00233-f004}

cancers-02-00233-t003_Table 3

###### 

Differentially expressed nuclear proteins identified by Westen blots in MCF7 and C4.12.5 cells.

  Gene       MCF7   C4.12.5   Nomenclature
  ---------- ------ --------- ------------------------------------------------
  BRCA1      1      0.3       Breast and ovarian cancer type I
  TOPOII     1      0         Type II topoisomerase
  IRS-I      0      0         Insulin receptor substrate-1
  PARP       1      2         Poly ADP ribose polymerase
  MET        1      0         Met tyrosine kinase
  p120       1      1.39      Zinc finger protein 120
  AR         1      0.64      Androgen receptor
  Sp1        1      0.79      Trans-acting transcription factor 1
  Foxo1      1      0.5       Forkhead Box A1
  ER         1      0.59      Estrogen receptor
  WT1        1      0.8       Wilms\' tumor suppressor gene-1
  KLF6       1      1.2       Kruppel-like factor 6
  LaminA/C   1      2.4       Nuclear protein
  Smad 2     1      1.12      Smad 2/3 family
  Smad 3     0      2.6       
  pSmad2/3   1      1.13      
  c-Myc      1      1.48      Myelocytomatosis oncogene
  E2F1       1      0.88      E2F transcription factor 1
  TCF1       1      0.717     T-cell factor 1
  TCF3A      1      0.002     High Mobility Group box transcription factor 3
  LEF1       1      1.15      Lymphoid enhancer binding factor 1
  p53        1      0.96      p53-related tumor suppressors
  p63        1      1.12      
  p73        1      0.03      
  p21        1      0.91      Waf1/Cip1
  GSK3α      1      1.05      Glycogen Synthase Kinase-3
  c-fos      1      0.92      c-fos/c-jun family of transcription factors
  c-jun      1      10        
  pc-jun     1      0.5       
  Cyclin G   1      0.13      Regulatory subunits of Cdc2 p34
  Cyclin D   1      0         
  Histone1   1      0.74      Nuclear protein

A value of 1 was assigned to the level of expression in whole MCF7 cell lysates, normalized to tubulin.

cancers-02-00233-t004_Table 4

###### 

Function of gene products identified in MCF7 and C4.12.5 cells by Western analyses.

  Gene        Function
  ----------- -------------------------------------------------------------------------------------------------------------------------
  BRCA1       Tumor suppressor involved in DNA damage repair, cell growth and apoptosis, and gene transcription.
  TOPOII      Type II topoisomerase, breaks double strands of duplex DNA.
  IRIS-I      Mediates insulin related activities.
  PARP        DNA repair, replication, transcription and cell death.
  MET         Receptor for HGF/SF.
  p120        Prototypical member of a subfamily of armadillo (Arm)-domain proteins involved in intercellular adhesion and in nuclei.
  AR          Androgen receptor (AR), a zinc finger transcription factor of the nuclear receptor superfamily.
  SP1         Transcription factor of the zinc finger family.
  Foxo1       Transcription factor of the forkhead family.
  ER          Estrogen receptor (ER), a DNA binding transcription factor of the nuclear receptor superfamily.
  WT1         Wilm's tumor suppressor protein-1.
  KLF6        Kruppel-like zinc finger transcription factor-6.
  LaminA/C    Involved in nuclear stability, chromatin structure and gene expression.
  pSmad 2/3   Smad transcription factors mediate the effect of TGF-β.
  Smad 2/3    
  c-Myc       Nuclear proteins involved in cell proliferation, differentiation and neoplastic disease.
  E2F1        Involved in cell cycle progression, apoptosis and oncogenesis.
  LEF1        Members of the high mobility group (HMG) DNA binding protein family of transcription factors.
  TCFA1       
  TCF3A       
  P53         Tumor suppressor p53, p63 and p73.
  p63         
  p73         
  GSK3α       Involved in protein synthesis, cell adhesion, proliferation, and differentiation.
  c-fos       Fos and Jun protooncogenes.
  c-junp      
  c-jun       
  Cyclin G    Regulatory subunits of Cdc2 p34 and related cyclin-dependent kinases (Cdks).
  Cyclin D    
  Histone1    Basic and water soluble nuclear proteins.
  p21         Tumor suppressor protein p21/Waf1/Cip1 acts as an inhibitor of cell cycle progression.

3.5. Cellular Distribution of IGF-IR Promoter-Binding Proteins
--------------------------------------------------------------

Given that differences in binding could be due to differential expression of the transcription factors in both cell lines, we next investigated the subcellular distribution and expression of IGF-IR promoter-binding transcription factors. For this purpose, MCF7 and C4.12.5 lysates were fractionated into cytoplasmic and nuclear fractions and the subcellular distribution of the different proteins was examined by Western blots ([Figure 5](#cancers-02-00233-f005){ref-type="fig"} and [Table 3](#cancers-02-00233-t003){ref-type="table"}, [Table 4](#cancers-02-00233-t004){ref-type="table"}). The cytosolic marker MET \[[@B47-cancers-02-00233]\] was used to check for cytoplasmic contamination of the nuclear fraction, and it was found to be expressed at very low levels in both cell lines. A number of proteins, including PARP (200% of levels in MCF7 cells), lamin (240%), Smad 2/3 (260%), and c-jun (1000%) had higher expression levels in C4.12.5 than in MCF7 cells. Other proteins, such as BRCA1 (30% of levels in MCF7), AR (64%), Sp1 (79%), Foxo I (50%), p73 (3%), TCF3A (0.2%), ER (59%), TCF1 (71.7%), pc-jun (50%), cyclin G (13%), and histone (74%) were expressed at lower levels in C4.12.5 compared to MCF7 cells. No differences in expression between the cell lines were detected in p120, c-fos, WT1, KLF6, pSmad2/3, c-Myc, p63, E2F, LEF1, p53, GSK3α, and p21. We were unable to detect expression of β-catenin, p300, TLE1, APC, and BRCA2 in neither cell line. Transcription factor WT1 was present in both cell lines, though its low molecular weight form appears to be specific to the MCF7 cell line.

![Cellular distribution of transcription factors in the MCF7 and C4.12.5 cell lines. Cell lines were fractionated as described under *Materials and Methods* and total lysates (T; 80 μg), cytosolic fractions (C; 20 μg), and nuclear extracts (N; 20 μg) were resolved on 10% SDS-PAGE and blotted with the indicated antibodies.](cancers-02-00233-g005){#cancers-02-00233-f005}

3.6. ChIP Assays
----------------

To corroborate results of DNA chromatography we measured the binding of selected proteins identified by MS or by Western blots using ChIP assays. The following proteins were chosen for ChIP assays: PARP (detected by MS and Western blots in both cell lines), Sp1 (positive control, detected in both cell lines), c-jun, (detected only in C4.12.5) and HMGA1 (detected by MS only in MCF7). Briefly, cells were lysed, sonicated for 3 min, and immunoprecipitated with the indicated antibodies (or normal mouse or rabbit sera) for 18 h ([Figure 6](#cancers-02-00233-f006){ref-type="fig"}A). In addition, MCF7 cells transfected with HA-HMGA1 (or empty pCDNA3 vector) were also immunoprecipitated with an HA monoclonal antibody ([Figure 6](#cancers-02-00233-f006){ref-type="fig"}B). For PCR analysis of immunoprecipitatd chromatin, a set of primers encompassing the human IGF-IR promoter was employed as described under *Materials and Methods* section. The input bands represent the amplified PCR product in the absence of antibodies ([Figure 6](#cancers-02-00233-f006){ref-type="fig"}A,B). The results of ChIP analyses confirmed that PARP, c-jun, Sp1, KLF6 and HMGA1 bound *in vivo* directly to the IGF-IR promoter and, thus, corroborate the results of MS and Western blot analyses.

![ChIP assays of transcription factor binding to IGF-IR promoter DNA. (**A**). MCF7 cells were cross-linked with formaldehyde, lysed, sonicated, and immunoprecipitated with PARP, c-jun, Sp1, or KLF6 antibodies, or normal mouse or rabbit sera, followed by PCR amplification of precipitated chromatin using primers encompassing the IGF-IR promoter. The position of the 773 bp-amplified fragments is indicated. The input bands represent the amplified PCR product in the absence of antibodies. The insets indicate the endogenous levels of expression of the various proteins as measured by Western blots (WB) with specific antibodies or NRS or NMS as negative controls. IP, immunoprecipitation. (**B**). MCF7 cells were transfected with an expression vector encoding HA-HMGA1 (or empty pcDNA3 vector), after which the cells were cross linked with formaldehyde, lysed, sonicated and immunoprecipitated with an HA antibody, followed by PCR amplification of IGF-IR promoter DNA. HA-HMGA1 immunoprecipitated protein was detected by Western blots using an anti-HA antibody (inset).](cancers-02-00233-g006){#cancers-02-00233-f006}

3.7. Regulation of IGF-IR Promoter Activity by c-jun, HMGA1, KLF6 and E2F1
--------------------------------------------------------------------------

To evaluate the potential functional implications of our findings we next assessed the ability of selected IGF-IR promoter-binding proteins to activate the promoter. For this purpose cotransfection experiments were performed in MCF7 and C4.12.5 cells using expression vectors encoding c-jun, HMGA1, KLF6 and E2F1, along with an IGF-IR promoter-luciferase reporter plasmid, p(−476/+640)LUC, which contains most of the proximal region of the IGF-IR promoter. The results of cotransfection experiments are presented in [Figure 7](#cancers-02-00233-f007){ref-type="fig"}A-D. Results obtained indicate that transcription factors c-jun, KLF6, and E2F1 induced a significant increase in IGF-IR promoter activity in both cells lines. Specifically, c-jun enhanced IGF-IR promoter activity by 445 ± 12.4% in MCF7 and by 209 ± 3.1% in C4.12.5 cells (*versus* empty vector), KLF6 enhanced promoter acitiviy by 237 ± 9.7% in MCF7 and by 159 ± 7.1% in C4.12.5 cells, and E2F1 stimulated promoter activity by 631.5 ± 44.5% in MCF7 and by 1127 ± 22.2% in C4.12.5 cells. On the other hand, HMGA1 had a minimal effect (131 ± 4.3% increase in MCF7 and 80.3 ± 1.7% reduction in C4.12.5 cells).

![Regulation of IGF-IR promoter activity by c-jun, HMGA1, KLF6 or E2F1. MCF7 and C4.12.5 cells were cotransfected with the p(−476/+640)LUC reporter construct along with c-jun (A), HMGA1 (B), KLF6 (C) or E2F1(D) expression plasmids (or empty expression vectors). Forty eight hours after transfection the cells were harvested and luciferase activity was measured. Promoter activities are expressed as luciferase values normalized to protein concentration. A value of 100% was given to the promoter activity generated by the reporter plasmid in empty vector-transfected MCF-7 or C4.12.5 cells. The results represent the mean ± SEM (N = 3 independent experiments in triplicate wells); \*p \< 0.01 versus empty vector-tranfected cells and ∗∗ p \< 0.01 versus specific vector-transfected MCF7 cells.](cancers-02-00233-g007){#cancers-02-00233-f007}

4. Discussion
=============

Breast cancer is one of the main causes of cancer-related mortality among women in economically developed regions of the world. Care of patients with breast cancer is complicated by the wide differences in the natural history of the disease, as manifested by a remarkable variability in response to treatment and survival. Over 100 potential biomarkers were reported in various studies to be differentially expressed between normal and cancerous cells and tissues. Cancer biomarkers include, among others, ER, progesterone receptor, HER2, cathepsin D, cyclin E, CA 15-3, and CA 27.29. Currently, only a few of those biomarkers are used in clinical practice. High-throughput genomic and proteomic techniques developed over the last decade offer the potential to better define the biological nature of the disease process, both for risk assessment and therapy purposes \[[@B48-cancers-02-00233]\].

There is conflicting evidence regarding the importance of IGF-IR expression for diagnosis and prognosis of breast cancer. In different studies, IGF-IR expression was detected in 39% to 93% of the cases \[[@B49-cancers-02-00233]\]. Whereas some studies reported that IGF-IR levels are indicative of early recurrence of the disease (*i.e*., poor prognosis), others considered high IGF-IR values as an indication of good prognosis \[[@B4-cancers-02-00233],[@B50-cancers-02-00233],[@B51-cancers-02-00233],[@B52-cancers-02-00233],[@B53-cancers-02-00233],[@B54-cancers-02-00233]\]. These disparities may be due to a number of factors, including selection of patients or the diverse approaches used to detect IGF-IR, including immunoblots of membrane fractions and/or whole tissues, ligand binding assays, *etc.* Immunohistochemical studies revealed high IGF-IR and IRS-1 levels in control breast tissues and in well-differentiated breast carcinoma, whereas very low levels were seen in poorly differentiated cancers \[[@B3-cancers-02-00233]\]. These results, suggesting that progression to advanced-stage disease is associated with a reduction in IGF-IR expression, indicate that IGF-IR status can be used as a marker for tumor evaluation \[[@B3-cancers-02-00233]\]. Notably, no correlation was seen between insulin receptor levels and the differentiation stage of the tumors.

In the present study we employed a novel and reliable DNA affinity chromatography protocol in order to identify IGF-IR promoter-binding proteins in breast cancer cells. This method allowed us to detect known and new specific potential biomarkers in ER-positive and ER-depleted cells, which may reflect early and advanced stages of the disease. Our analyses identified twenty four proteins that bind to the IGF-IR promoter only in MCF7 cells whereas, on the other hand, C4.12.5 cells contain nineteen proteins that did not exhibit IGF-IR promoter binding activity in MCF7 cells. The results obtained suggest that the specific binding of different DNA-binding transcription factors and non-DNA sequence specific-binding nuclear proteins (including Smad2/3, LEF1, c-jun, TCF1A, TCF3A, GSK3β and others ) in the MCF7 and C4.12.5 cell lines could reflect differences in transcriptional regulation of the IGF-IR gene at different stages of the disease. Interestingly, sixty two proteins were shown to bind (either directly or indirectly) to IGF-IR promoter elements in both cell lines. As shown in [Table 2](#cancers-02-00233-t002){ref-type="table"} and [Table 4](#cancers-02-00233-t004){ref-type="table"}, the list of proteins identified in this study includes proteins involved in apoptosis, protein synthesis, cell adhesion, proliferation, differentiation, nuclear stability, chromatin structure, DNA repair, recombination, replication, tumor suppression, and oncogenesis. In this context, it has been previously shown that the regulatory region of the IGF-IR gene constitutes a molecular target for a number of transcription factors with tumor suppressor or stimulatory activity \[[@B46-cancers-02-00233]\]. Under normal physiological conditions, IGF-IR expression is tightly regulated by complex interactions involving positively acting (Sp1, KLF-6, ERα) and negatively acting (p53, p73, BRCA1, ATM, WT1, VHL) transcription factors \[[@B17-cancers-02-00233],[@B18-cancers-02-00233],[@B22-cancers-02-00233],[@B23-cancers-02-00233],[@B24-cancers-02-00233],[@B40-cancers-02-00233],[@B45-cancers-02-00233],[@B55-cancers-02-00233],[@B56-cancers-02-00233],[@B57-cancers-02-00233],[@B24-cancers-02-00233],[@B40-cancers-02-00233],[@B45-cancers-02-00233],[@B55-cancers-02-00233]\]. Elevated IGF-IR levels were postulated to be the result of loss-of-function mutations of tumor suppressor genes in cancer cells \[[@B58-cancers-02-00233]\]. The approach employed in this study allowed us to identify several previously reported IGF-IR promoter-binding proteins, including Sp1, KLF6, and WT1. Moreover, results of MS and Western blots confirmed bioinformatic predictions on transcription factor binding sites (e.g., WT1, ER, E2F, Sp1, *etc.*), obtained using the TRANSFAC and AliBaba2 softwares (<http://www.biobase-international.com> and <http://www.gene-regulation.com>) (data not shown). Furthermore, the fact that we were able to detect differences in promoter binding between the two cell lines, despite the lack of differences in protein expression, indicates that the DNA affinity chromatography approach used was highly specific and sensitive. Given that differences in binding could be due to differences in the availability of these proteins, we confirmed that the proteins detected in the eluates were truly present in the nuclear fractions. Several proteins, including KLF6, Smad2/3, GSK3β, c-jun, and p21, were present in both cytosolic and nuclear fractions. A number of transcription factors, including BRCA1, p120, Foxo1, p73, c-myc, p63, cyclin D and G, were undetectable in eluates of both cell lines. A potential explanation for these results is the fact that the expression of these transcription factors was very low in the nuclear fractions \[[@B59-cancers-02-00233]\] or, alternatively, that they are engaged in multi-protein complexes and, therefore, cannot bind to IGF-IR promoter sequences.

The capacity of a number of proteins identified by MS and/or Western blots (PARP, Sp1, c-jun, HMGA1) to directly bind to IGF-IR promoter DNA *in vivo* was confirmed by ChIP assays. Furthermore, the functional relevance of binding data was addressed by coexpression experiments which revealed that c-jun, KLF6, and E2F1 significantly enhanced IGF-IR promoter activity. Differences in the capacity of these factors to stimulate IGF-IR promoter activity was seen between both cell lines. The luciferase assays corroborate the results obtained by Western blots and ChIP assays. We have previously shown using EMSA and ChIP that both Sp1 and ERα bind to the IGF-IR promoter and stimulate gene transcription, whereas no ERα binding was seen in C4 cells \[[@B60-cancers-02-00233]\]. In addition, we have reported that Sp1 increased IGF-IR promoter activity with a 5.8-fold higher potency in MC7 than in C4 cells \[[@B60-cancers-02-00233]\]. Taken together, there is a remarkable consistency between the various technological approaches used to identify IGF-IR promoter-binding transcription factors.

5. Conclusions
==============

In summary, using DNA affinity chromatography we identified a collection of known and novel IGF-IR promoter-binding transcription factors in breast cancer cell lines. These proteins may constitute potential biomarkers characteristic of ER-positive or ER-negative tumors. The potential clinical relevance of our results need to be confirmed by future studies on biopsies from patients at early and advanced stages, and need to be correlated with conventional prognostic factors such as tumor size, lymph nodes status, histological grade, and ER status.
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IGF-IR:

:   Insulin-like growth factor I receptor

ER:

:   Estrogen receptor
